We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Three Petition Denials Indicate FDA Won’t Predetermine ANDA Requirements
Three Petition Denials Indicate FDA Won’t Predetermine ANDA Requirements
February 12, 2013
The FDA has denied three separate citizen petitions from Purdue Pharma, Endo Pharmaceuticals and Mallinckrodt that asked the agency to impose specific conditions on generic versions of their painkillers.